Drugs Made In America Acquisition II Corp. Rights (DMIIR)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 08
+0.01
+12.3755%
$
5.91M Market Cap
- P/E Ratio
- Div Yield
60,046 Volume
- Eps
$ 0.07
Previous Close Want to track DMIIR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition II Corp. Rights Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| IH Isaac Haas Hbk Investments LP | 500,000 | $70,000 | $40,000 | -$30,000 | -42.86% |
| SK Steven Katznelson Radcliffe Capital Management LP | 575,000 | $80,500 | $46,000 | -$34,500 | -42.86% |
| VL Vincent Leva Linden Advisors LP | 899,899 | $125,985.86 | $71,991.92 | -$53,993.94 | -42.86% |
| BO Brian Oliveira Clear Street Group Inc. | 297,716 | $25,452.68 | $23,847.05 | -$1,605.63 | -6.31% |
| MCS Mercuria Capital Strategies LLC Mercuria Capital Strategies LLC | 750,000 | $60,000 | $60,000 | - | - |
| AAS ABC Arbitrage SA ABC Arbitrage SA | 40,000 | $5,600 | $3,200 | -$2,400 | -42.86% |
